The global Soliris market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.
Prior to COVID-19, the China market for Soliris was anticipated to grow from US$ 43.15 million in 2020 to US$ 105.67 million by 2026; it is expected to grow at a CAGR of 14.86% during 2021–2026, whereas post-COVID-19 scenario, the market for Soliris is projected to grow from US$ 40.9 million in 2020 (a change by ~-6.4% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ 100.58 million by 2026; it is expected to grow at a CAGR of 14.75% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Soliris market.The classification of Soliris includes Plasma Exchange and Plasma Infusion, and the proportion of Plasma Exchange in 2019 is about 76.36%, and the proportion is in increasing trend from 2013 to 2018.
Soliris is widely used for patients of PNH, aHUS and other. The most proportion of Soliris is used for patients of PNH, and the proportion in 2019 is 66.85%.
The “Soliris Industry Forecast” looks at past sales and reviews total world Soliris sales in 2024, providing a comprehensive analysis by region and market sector of projected Soliris sales for 2025 through 2031. With Soliris sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Soliris industry.
This Insight Report provides a comprehensive analysis of the global Soliris landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Soliris portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Soliris market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Soliris and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Soliris.
This report presents a comprehensive overview, market shares, and growth opportunities of Soliris market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Plasma Exchange
Plasma Infusion
Segmentation by Application:
PNH
aHUS
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Alexion
Key Questions Addressed in this Report
What is the 10-year outlook for the global Soliris market?
What factors are driving Soliris market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Soliris market opportunities vary by end market size?
How does Soliris break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Soliris Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Soliris by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Soliris by Country/Region, 2020, 2024 & 2031
2.2 Soliris Segment by Type
2.2.1 Plasma Exchange
2.2.2 Plasma Infusion
2.3 Soliris Sales by Type
2.3.1 Global Soliris Sales Market Share by Type (2020-2025)
2.3.2 Global Soliris Revenue and Market Share by Type (2020-2025)
2.3.3 Global Soliris Sale Price by Type (2020-2025)
2.4 Soliris Segment by Application
2.4.1 PNH
2.4.2 aHUS
2.4.3 Other
2.5 Soliris Sales by Application
2.5.1 Global Soliris Sale Market Share by Application (2020-2025)
2.5.2 Global Soliris Revenue and Market Share by Application (2020-2025)
2.5.3 Global Soliris Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Soliris Breakdown Data by Company
3.1.1 Global Soliris Annual Sales by Company (2020-2025)
3.1.2 Global Soliris Sales Market Share by Company (2020-2025)
3.2 Global Soliris Annual Revenue by Company (2020-2025)
3.2.1 Global Soliris Revenue by Company (2020-2025)
3.2.2 Global Soliris Revenue Market Share by Company (2020-2025)
3.3 Global Soliris Sale Price by Company
3.4 Key Manufacturers Soliris Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Soliris Product Location Distribution
3.4.2 Players Soliris Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Soliris by Geographic Region
4.1 World Historic Soliris Market Size by Geographic Region (2020-2025)
4.1.1 Global Soliris Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Soliris Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Soliris Market Size by Country/Region (2020-2025)
4.2.1 Global Soliris Annual Sales by Country/Region (2020-2025)
4.2.2 Global Soliris Annual Revenue by Country/Region (2020-2025)
4.3 Americas Soliris Sales Growth
4.4 APAC Soliris Sales Growth
4.5 Europe Soliris Sales Growth
4.6 Middle East & Africa Soliris Sales Growth
5 Americas
5.1 Americas Soliris Sales by Country
5.1.1 Americas Soliris Sales by Country (2020-2025)
5.1.2 Americas Soliris Revenue by Country (2020-2025)
5.2 Americas Soliris Sales by Type (2020-2025)
5.3 Americas Soliris Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Soliris Sales by Region
6.1.1 APAC Soliris Sales by Region (2020-2025)
6.1.2 APAC Soliris Revenue by Region (2020-2025)
6.2 APAC Soliris Sales by Type (2020-2025)
6.3 APAC Soliris Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Soliris by Country
7.1.1 Europe Soliris Sales by Country (2020-2025)
7.1.2 Europe Soliris Revenue by Country (2020-2025)
7.2 Europe Soliris Sales by Type (2020-2025)
7.3 Europe Soliris Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Soliris by Country
8.1.1 Middle East & Africa Soliris Sales by Country (2020-2025)
8.1.2 Middle East & Africa Soliris Revenue by Country (2020-2025)
8.2 Middle East & Africa Soliris Sales by Type (2020-2025)
8.3 Middle East & Africa Soliris Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Soliris
10.3 Manufacturing Process Analysis of Soliris
10.4 Industry Chain Structure of Soliris
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Soliris Distributors
11.3 Soliris Customer
12 World Forecast Review for Soliris by Geographic Region
12.1 Global Soliris Market Size Forecast by Region
12.1.1 Global Soliris Forecast by Region (2026-2031)
12.1.2 Global Soliris Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Soliris Forecast by Type (2026-2031)
12.7 Global Soliris Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Alexion
13.1.1 Alexion Company Information
13.1.2 Alexion Soliris Product Portfolios and Specifications
13.1.3 Alexion Soliris Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Alexion Main Business Overview
13.1.5 Alexion Latest Developments
14 Research Findings and Conclusion
Ěý
Ěý
*If Applicable.
